Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2020 Sep 11;59(43):19121–19128. doi: 10.1002/anie.202008226

Membrane Chemistry Tunes the Structure of a Peptide Transporter

Tanya Lasitza‐Male 1,, Kim Bartels 3,, Jakub Jungwirth 2, Felix Wiggers 1, Gabriel Rosenblum 1, Hagen Hofmann 1,, Christian Löw 3,4,
PMCID: PMC7590137  PMID: 32744783

Abstract

Membrane proteins require lipid bilayers for function. While lipid compositions reach enormous complexities, high‐resolution structures are usually obtained in artificial detergents. To understand whether and how lipids guide membrane protein function, we use single‐molecule FRET to probe the dynamics of DtpA, a member of the proton‐coupled oligopeptide transporter (POT) family, in various lipid environments. We show that detergents trap DtpA in a dynamic ensemble with cytoplasmic opening. Only reconstitutions in more native environments restore cooperativity, allowing an opening to the extracellular side and a sampling of all relevant states. Bilayer compositions tune the abundance of these states. A novel state with an extreme cytoplasmic opening is accessible in bilayers with anionic head groups. Hence, chemical diversity of membranes translates into structural diversity, with the current POT structures only sampling a portion of the full structural space.

Keywords: FRET, biomembranes, membrane proteins, protein structures, single-molecule studies


Single‐molecule FRET experiments show that the structure of the peptide membrane transporter DtpA is tuned by membrane composition. Head‐group chemistry determines which of three alternative conformations dominates. An extreme cytoplasmic opening is observed with anionic head groups.

graphic file with name ANIE-59-19121-g006.jpg

Introduction

Membrane proteins with their ability to shuttle, pump, exchange, and transmit signals across lipid bilayers1, 2, 3, 4, 5, 6, 7 represent 30 % of proteins in living organisms8, 9 and 60 % of current drug targets.10, 11 While membranes are key for their function,12, 13, 14, 15, 16, 17 methods such as x‐ray crystallography or cryo‐electron microscopy often require detergent extraction for obtaining high‐resolution structures.18, 19, 20, 21, 22, 23, 24 Unfortunately, it is unclear whether structure and function of these pharmacologically important proteins are preserved in such artificial environments.25, 26 We address this question by comparing the conformations of a major facilitator superfamily (MFS) transporter between detergent and membrane‐mimicking environments using single‐molecule Förster resonance energy transfer (smFRET).

The MFS is one of the largest families of membrane transporters in nature.27, 28 It mediates the uptake of a broad spectrum of substrates and is therefore key for maintaining cell homeostasis.29 MFS transporters work via an alternate access mechanism30, 31 that requires at least three states:32, 33 inward‐open, occluded, and outward‐open (Figure 1 A). Members of the MFS share a common fold:34 twelve transmembrane helices organized in two six‐helix bundles (Figure 1 B). A particularly important subfamily are proton‐dependent oligopeptide transporters (POTs)27 that utilize a proton gradient35 to uptake di‐ and tripeptides but also peptide‐mimetic drugs.36, 37 Their remarkable substrate promiscuity38, 39 makes them important targets for drug delivery. Numerous bacterial POT structures have been determined to date.40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57 We focus on the E. coli peptide transporter DtpA58, 59 (Figure 1 B), a homolog of human PepT1 and PepT2.36, 60, 61, 62, 63, 64, 65, 66 Its similar substrate specificity compared to human homologs makes DtpA an ideal prototype to understand the mechanism of peptide and drug transport.48 However, current x‐ray structures of POTs in detergents revealed mainly inward‐open conformations,40, 43, 44, 45, 46, 47, 48, 49, 51, 52 thus hampering an atomic level understanding of the transport cycle. This bias may be symptomatic for non‐natural detergent environments, thus calling for in‐depth comparison of POT conformations in detergent and lipid environments.

Figure 1.

Figure 1

Transport mechanism and functionality of DtpA. A) Schematics of the alternate access mechanism. Substrate (gray sphere) transport requires alternate access of the substrate‐binding center to each membrane side. B) Structure of DtpA (gray), including the positional distribution (see Methods in the Supporting Information) of the FRET dyes (pink, green). C) Thermal stability of wildtype DtpA and the variant WQ in its unlabeled (WQ) and labeled (WQDA) form in the absence and presence of different ligands (indicated). D) Nanobody affinity to wildtype DtpA (blue) and the variants WQ before (green) and after labeling (orange). E) In vivo AMCA uptake efficiency of wildtype DtpA and the variant WQ.

Results and Discussion

We labeled DtpA on its cytoplasmic side (Figure 1 A,B and SI Appendix, Figure S1) using the variant W203C/Q487C (WQ). The intrinsic cysteines were replaced by serine residues. WQ is fully functional in binding ligands (Figure 1 C and SI Appendix, Figure S2–5) and a conformation‐specific nanobody (N00) (Figure 1 D and SI Appendix, Figure S6,7, Table S2), and it shows high transport activity in an in vivo uptake assay (Figure 1 E and SI Appendix, Figure S8). Similarly, labeling with donor (Alexa Fluor 488) and acceptor (Alexa Fluor 594) neither impaired the thermal stability of the transporter (Figure 1 C and SI Appendix, Figure S3), nor N00 binding (Figure 1 D and SI Appendix, Figure S6,7, Table S2). Notably, an alternative variant W203C/T351C (WT) shows results identical to those of the WQ variant (SI Appendix, Figure S1–3, S7–9, S10–12, Table S2).

Structure and Dynamics of DtpA in Detergent

The detergent LMNG (lauryl‐maltose‐neopentyl‐glycol) is commonly used to extract membrane proteins and to determine their structure using x‐ray crystallography and cryo‐EM.20, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77 We therefore probed the conformation of freely diffusing DtpA in LMNG. The FRET histogram shows two peaks: a minor peak at high FRET (E=0.89) and a major peak at lower FRET (E=0.48) (Figure 2 A). Although the FRET efficiency of the major peak agrees with the value computed from the x‐ray structure of the inward‐open state (0.54) (Methods), its donor fluorescence lifetime deviates from the expected value for a single donor‐acceptor distance (Figure 2 A), suggesting a distribution instead of a defined structure.78, 79, 80 A fit with an empirical model81 results in a distance distribution width of 1.1 nm (Methods), suggesting variability in the opening of the cytoplasmic side (Figure 2 A, inset). Notably, a static distribution of dye rotamers on a rigid x‐ray structure would only cause a distribution width of 0.78 nm (Figure 2 A, inset). Yet, since fluorescence anisotropy measurements show that the dyes experience sufficient rotational freedom (Figure S12) at the timescale of the donor fluorescence lifetime, the distribution of dye positions only contributes moderately to the donor lifetime. Importantly, the structural variability of DtpA is accompanied by substantial pliability. With decreasing temperature, the FRET efficiency of the major peak shifts to lower values, thus causing an even wider opening (Figure 2 B). The result is remarkable because positional shifts of FRET peaks indicate (i) reconfiguration timescales faster than the diffusion of the protein through the confocal spot of our microscope (<1 ms) and (ii) large‐scale structural adaptations to external conditions, which are known for intrinsically disordered and unfolded proteins,82, 83 but not for well‐folded proteins such as DtpA. Contrary to the picture sketched by the x‐ray structure of DtpA, the results show that the inward‐open form of DtpA is a flexible conformational ensemble that is sampled at sub‐millisecond timescales. However, what is the structural origin of the minor high‐FRET population?

Figure 2.

Figure 2

SmFRET of DtpA in detergent. A) FRET histogram of WQDA in LMNG (top). Solid lines are fits with Gaussian and log‐normal peaks to account for open (blue) and closed (red) molecules. Molecules that lack an active acceptor are shown in gray. (bottom) 2D correlation map between donor fluorescence lifetime and transfer efficiency. Solid lines show the dependence for a single donor‐acceptor distance (black) and the best fit of the mean position of open molecules (white cross) with a distance distribution (blue). Inset: The distance distribution obtained from the fit (blue) and the expected distance distribution for the rigid X‐ray structure assuming a static positional distribution of the dyes (orange). B) FRET histograms of DtpA at different temperatures. The position of the open population is indicated by the shaded area. C,D) Same as (A,B) in the presence of N00 (8 μm).

Given our labeling at the cytoplasmic side (Figure 1 B), molecules with high FRET exhibit a closed cytoplasmic side. Based on the alternate access model,30, 31, 33 a closed cytoplasmic side is indeed expected for outward‐open or occluded conformations (Figure 1 A). Unfortunately, the sensitivity of our FRET‐probes (2–8 nm) is insufficient to distinguish between these states and we therefore used a biochemical approach. The addition of the conformation‐specific nanobody (N00) blocks the opening of the periplasmic side (Figure 2 C). If the high‐FRET peak represents outward‐open molecules, blocking the periplasmic opening is expected to shift the equilibrium towards the low‐FRET peak (inward‐open) due to the mutually exclusive nature of these states.

However, despite a nanomolar affinity for DtpA (Figure 1 D, Table S2), N00 neither changes the abundance of the high‐FRET peak (Figure 2 C) nor does it alter the temperature adaptation of the inward‐open ensemble (Figure 2 D). Two scenarios could explain this result: either the high‐FRET peak corresponds to an occluded conformation with simultaneously closed cytoplasmic and periplasmic sides, or the high‐FRET peak is not in equilibrium with the open ensemble, suggesting that it represents kinetically trapped misfolded species. To exclude the latter, we checked whether the high‐ and low‐FRET peaks are in dynamic exchange.

Here, we made use of the fact that a diffusing molecule may enter and exit the confocal spot numerous times (Figure 3 A). Once a molecule leaves the observation volume, the likelihood of it returning to this volume within a short time period is larger than the chance of detecting a new molecule. Hence, conformational switching events between successive transits can be identified (Figure 3 A), which allows us to probe dynamics in the regime of several milliseconds.84, 85 To extract the exchange kinetics, we binned the photon trace (100 μs steps) and selected all molecules in the high‐FRET population (0.7<E<1.2). We then constructed FRET histograms of those bins that followed the original set with a time delay. With increasing time delay, the high‐FRET population decreases and the low‐FRET population increases (Figure 3 B). The kinetics of forming low‐FRET molecules from the high‐FRET species follows single‐exponential kinetics with a relaxation time of ≈1 ms (Figure 3 C) that clearly demonstrates an exchange between the peaks. Misfolding can therefore be excluded as an origin of the high‐FRET peak. Notably, full equilibration is not reached within the accessible time window (Figure 3 C), indicating that also slower processes contribute to the exchange. Importantly, the exchange is also observed in the presence of N00 (Figure 3 D), which shows that opening and closing of the cytoplasmic side is independent of locking the periplasmic side. This loss in cooperativity between sides strongly indicates that the high‐FRET peak represents occluded molecules with simultaneously closed cytoplasmic and periplasmic sides. Indeed, such states have previously been found in detergent‐based x‐ray structures,43, 46, 86 but the timescale of their formation had been elusive.

Figure 3.

Figure 3

Dynamic exchange between high‐ and low‐FRET peaks. A) Schematics of a single‐molecule time trace of donor (green) and acceptor (red) signal. The multiple detection of two molecules due to their recurring passages through the confocal spot (orange) is shown. Switching between states is indicated (arrows). B) Single‐molecule recurrence histograms at two‐time delays (indicated) after initially selecting high‐FRET molecules (initial) show the time‐dependent rise of low‐FRET species. C) Time trace of the formation of low‐FRET molecules (blue) and a single‐exponential fit (black line). Dashed line indicates the equilibrium fraction of the low‐FRET population. D) Same as (C) in the presence of 8 μm N00. E) Relative abundance of high‐FRET molecules in the absence and presence of di‐ and tri‐peptides (indicated).

Occluded molecules are intermediates on the path from outward‐open to inward‐open states (Figure 1 A). Given the underrepresentation of outward‐open x‐ray structures,40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57 we utilized our smFRET approach to identify detergent conditions that stabilize the outward‐open conformation. To this end, we screened a broad spectrum of ligands (Figure 3 E and SI Appendix, Figure S13) with the goal to shift the balance between high‐ and low‐FRET peaks. However, none of the ligands and not even changes in the protonation state of DtpA (SI Appendix, Figure S14) altered the balance between high‐ and low‐FRET peaks significantly, suggesting that detergent does not provide the means to stabilize outward‐open molecules. This raises the general question of whether outward‐open states are sampled at all in the absence of proton‐ and substrate‐gradients. To address this question, we studied DtpA in membrane‐like nanoparticles stabilized by the protein Saposin A (SapNPs).87, 88

Conformation and Dynamics of DtpA in SapNPs

We reconstituted DtpA in SapNPs composed of POPE (1‐Palmitoyl‐2‐oleoyl‐sn‐glycero‐3‐phosphoethanol‐amine), the most abundant phospholipid in E. coli 89 (Figure 4 A and SI Appendix, Figure S4, S15,16). The FRET histogram of DtpA in SapNPs differs from that obtained in detergent (Figure 4 B).

Figure 4.

Figure 4

Conformational distribution of DtpA in SapNPs. A) Schematics of DtpA (dark gray) in a lipid SapNP stabilized by saposin A (green). Lipids are shown in gray. B) SmFRET histogram of DtpA in POPE SapNPs in the absence (top) and presence (bottom) of 8 μm N00. The position and width of the low‐FRET peak had first been determined in the presence of N00. The same parameters were then used to fit the histogram in the absence of N00. C) Time trace of the formation of low‐FRET molecules in POPE SapNPs in the absence (blue) and presence (red) of N00. Black line is a single‐exponential fit of the data. D–F) Same as B in SapNPs composed of POPS (D), POPA (E), and brain lipid extract (F). In eukaryotic brain lipid extract, 58.7 % of the lipid composition is unspecified by the manufacturer but likely contains >50 % PC.90

While the peaks at low and high FRET efficiency are preserved, the histograms are broader. Still, the fluorescence lifetimes indicate that the peaks correspond to a distribution of conformers (SI Appendix, Figure S16). Since control experiments exclude quenching and a sticking of the FRET‐dyes to the protein surface (SI Appendix, Figure S12, S17), we conclude that peak broadening is due to a slower sampling within the open and closed ensembles. Compared to detergent, the abundance of the high‐FRET peak has nearly doubled (29 %), indicating an increased population of occluded or outward‐open states. Indeed, when we now add N00 to block the opening of the periplasmic side, we find a significant reduction of the high‐FRET population (Figure 4 B), suggesting that a dominant portion of the high‐FRET peak represents outward‐open conformers.

Clearly, the cooperativity between the cytoplasmic and periplasmic side has been restored, thus making the outward‐open state accessible. Apparently, a lipid environment is required to sample outward‐open states. It is unclear, however, whether occluded states are also populated in POPE SapNPs. Yet, given the results of our experiments in detergent, we can identify them based on their rapid millisecond formation. Indeed, also in POPE SapNPs, we find open‐close kinetics with a decay time of 1 ms, irrespective of the presence of N00 (Figure 4 C), indicating a fast cytoplasmic opening and closing despite a locked periplasmic side. Occluded conformers are therefore found under all conditions whereas the outward‐open conformation is only populated in POPE containing SapNPs. This finding raises an important question: is a lipid bilayer per se sufficient to populate outward‐open ensembles or are special lipid head groups, e.g., ethanolamine in POPE required? To answer this question, we reconstituted DtpA in lipid environments of different composition (Figure 4 D–F): POPS (1‐palmitoyl‐2‐oleoyl‐sn‐glycero‐3‐phospho‐l‐serine), POPA (1‐palmitoyl‐2‐oleoyl‐sn‐glycero‐3‐phosphate), or BL (brain lipid) extract. Surprisingly, the FRET histograms differ strongly among the four membrane environments. In total, three populations can be distinguished. The high‐ and low‐FRET peaks are identical to those found in POPE. However, an additional peak with an extremely low FRET efficiency (E=0.25±0.02) is found in POPS and POPA (Figure 4 D,E) that corresponds to an ensemble with an extreme opening of the cytoplasmic side. In BL‐extracts on the contrary, neither high‐ nor low‐FRET peaks are observed and the transporter samples exclusively inward‐open conformations (Figure 4 F). Hence, DtpA exhibits a strong sensitivity to the lipid composition and net negatively charged lipids (POPS, POPA) even cause an extreme opening. Importantly, irrespective of the membrane composition, we find a strong cooperativity between the cytoplasmic and periplasmic side of the transporter: when N00 binds the periplasmic side, all populations collapse to predominantly form the inward‐open ensemble (Figure 4 B, D–F). The results indicate that it is the membrane environment per se that generates the cooperativity between the hemispheres of DtpA rather than the chemical nature of the lipid head group. Head group chemistry on the contrary, sensitively tunes the abundance of states. However, this is not the case for ligands. Similar to our findings in detergent, the addition of ligands to DtpA in POPE SapNPs did not affect the relative abundance of inward‐open and outward‐open states (SI Appendix, Figure S19). Although the detergent‐based inward‐open x‐ray structure with a pro‐drug bound is also similar to the apo‐structure,48 the lacking structural sensitivity to ligands is surprising. However, in cells, ligand concentrations differ significantly between periplasm and cytoplasm, thus generating an asymmetry that is not reproduced in our experiments. If ligand affinities are similar at each side of DtpA, the isotropic concentration of ligand on both sides in our experiments will cause a structural invariance of DtpA towards the ligand.

Structural Modeling of DtpA Conformations

The extreme inward‐open population observed in SapNPs containing POPS and POPA remains a conundrum. To obtain an estimate of the domain arrangement, we started from the existing x‐ray structure of DtpA and used rigid‐body rotations of the N‐ and C‐terminal domains (Figure 5 A–D). Current transport models33 suggest symmetric motions around the center axis that crosses the substrate‐binding site at the domain interface (Figure 5 A). We therefore rotated the domains around this axis and determined the FRET efficiency of the rotamers (see Methods in the Supporting Information). We find that closing the cytoplasmic side by rotating the domains by −40° reproduces the experimental FRET efficiency (0.82) of the outward‐open ensemble with only introducing 4.8 % atomic clashes91 (Figure 5 B).

Figure 5.

Figure 5

Structural models of the DtpA conformers. A) Schematics of DtpA rigid‐body rotations around the center axis. B) FRET efficiency (black) and clash score (red) for rotations around the center axis. C,D) Same as (A) and (B) for rotations around the periplasmic axis. E) Models of the outward‐open (left) and extreme inward‐open (right) states based on rigid‐body domain rotations of the X‐ray structure (middle).

However, it is impossible to match the experimental FRET efficiency of the extremely inward‐open ensemble without inacceptable clashes. We therefore chose an alternative rotation axis on the periplasmic side (Figure 5 C). Here, the extreme inward‐opening can indeed be reproduced with only 2.4 % atomic clashes (Figure 5 D). Notably, we did not optimize these structures, which shows that the domain architecture in principle allows an extreme cytoplasmic opening of DtpA (Figure 5 E).

Interestingly, like all bacterial POTs, DtpA contains two transmembrane helices (HA and HB) that are missing in eukaryotic homologs.48 The interaction between these helices and the core of DtpA hinders the formation of the outward‐open state via rigid body rotations and we therefore neglected the connecting loop between HA and HB in our rigid‐body motion approach (Figure 5 E). Neglecting these restraints is justified by the fact that the interface between both helices and DtpA is rich in hydrophobic residues. We conjecture that while these helices are strongly attached to DtpA in the more water‐rich detergent environment25 due to hydrophobic effects, this interaction is weakened in the strongly hydrophobic environment of a lipid bilayer. Weakening contacts between the helices and the DtpA core would release the restraints that hamper an opening of the periplasmic side such that this mechanism explains why the outward‐open state is only observed in membrane‐mimicking SapNPs (Figure 4).

Conclusion

POTs have been extensively studied by x‐ray crystallography and biochemical transport assays over the past years.27, 36, 39, 58, 61, 64, 92, 93 Numerous structures of various bacterial homologues in the absence and presence of substrates, drugs, and prodrugs are available, highlighting crucial residues for substrate binding and proton coupling.40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50 Unfortunately, only inward‐open and partially inward‐open states of POTs have so far been described at atomic resolution in detergent and the influence of the membrane environment on structure and transport has been difficult to access.40, 41, 43, 44, 46, 49, 54 A number of reports showed that the activity of membrane proteins is preserved in detergent environments.94, 95, 96 Yet, counter examples are also frequent. For example, G‐protein coupled receptors (GPCRs) are known to be sensitive to the sterol content of lipid bilayers97 and their membrane extraction is often cell‐type dependent.98 Structural differences in a scramblase between detergent and membrane‐like environments have recently been found using cryo‐EM.99 Hence, the way lipid compositions affect structure and function of membrane proteins in vitro varies and it is often unclear whether a loss of function in detergent is caused by a loss in stability or by trapping the protein in one out of several functional conformers. While the latter is clearly preferred, it complicates the crystallization of all functionally relevant states. This is particularly problematic for POTs whose broad substrate profile makes them key for the pharmacokinetics of drugs. Using DtpA, we showed that the crystallization bias of POTs results from a strong sensitivity towards the lipid environment. Detergents do not allow a sampling of all functional states of DtpA. Although our smFRET experiments show that the inward‐open conformation in detergent is similar to that in POPE nanoparticles (Figure 2 A and B), the outward‐open state is only accessible in the more native environment of SapNPs. Structurally, a weakening of the hydrophobic contacts between the helices HA/HB and the core of DtpA in the low dielectric medium of a membrane explains this sensitivity (Figure 5 E). However, structural differences are not only observed between detergent and SapNPs but also between SapNPs with different lipid composition. In fact, since the aliphatic tails of POPA, POPS, and POPE are identical, the difference in the abundance of inward‐open, extreme inward‐open, and outward‐open conformers (Figure 4) is caused by the chemistry of lipid head groups. For example, the newly identified extreme inward‐open conformation is only observed in POPA and POPS, i.e., lipids with net negatively charged head groups. Given the complexity of natural membranes in which lipid compositions can vary on sub‐micrometer length scales, e.g., in micro‐domains,100 the heterogeneity found among four membrane‐like environments in our experiments may suggest a structurally heterogeneous DtpA ensemble in the cell membrane.

Care has to be taken when interpreting functional and pharmacological aspects based on structures obtained in detergents. While these structures suggest models with well‐defined states, our results sketch DtpA as an ensemble of multiple conformers with rapid dynamics. Recent studies showed that enzymes obey structural dynamics much faster than the timescales required for turnover.101, 102 Such dynamics are also prevalent in DtpA, irrespective of the lipid environment (Figure 3 C,D and Figure 4 C). Not only do inward‐open and occluded states interconvert rapidly with a relaxation time of 1 ms, but the inward‐open state itself is an ensemble of conformers within which the opening of the cytoplasmic side can vary (Figure 2 A). Although the role of these dynamics in the substrate transport cycle is currently elusive, fast domain closures in adenylate kinase have been proposed to optimize the orientation of substrate for catalysis101 and a similar mechanism could guide the POT‐mediated transport of peptides across biological membranes.

In summary, our results show that DtpA is a flexible and highly dynamic ensemble of structures that responds sensitively to its lipid environment and it will be important to understand whether this sensitivity is a general feature of MFS transporters.

Conflict of interest

The authors declare no conflict of interest.

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary

Acknowledgements

We thank the Sample Preparation and Characterization facility at EMBL (Hamburg, Germany) for their support with biophysical measurements and Dr. Haydyn Mertens of EMBL (Hamburg, Germany) for generating the model of DtpA in SapNPs. We thank Prof. Phillip Selenko of the Weizmann Institute of Science (Rehovot, Israel), Prof. Jordan Chill, and Dr. Inbal Sher of the Bar Ilan University (Israel) for the fruitful discussions concerning the reconstitution of membrane proteins in nanodiscs. We thank Rose Irwin of the Weizmann Institute of Science (Rehovot, Israel) for assistance with application of Eisenberg hydrophobicity segregation script. Dr. Hofmann thanks the Benoziyo Fund for the Advancement of Science, the Carolito Foundation, the Gurwin Family Fund for Scientific Research, and the Leir Charitable Foundation. This work was funded by a joint grant from the German‐Israeli Foundation (GIF grant #G‐1288‐207.9/2015) to Dr. Hagen Hofmann and to Dr. Christian Löw. Open access funding enabled and organized by Projekt DEAL.

T. Lasitza-Male, K. Bartels, J. Jungwirth, F. Wiggers, G. Rosenblum, H. Hofmann, C. Löw, Angew. Chem. Int. Ed. 2020, 59, 19121.

A previous version of this manuscript has been deposited on a preprint server (https://doi.org/10.1101/2020.01.09.900316).

Contributor Information

Dr. Hagen Hofmann, Email: hagen.hofmann@weizmann.ac.il.

Dr. Christian Löw, Email: christian.loew@embl-hamburg.de.

References

  • 1. Cowden R. R., DeRobertis E. D. P., DeRobertis E. M. F., Cell and Molecular Biology, Lea & Febiger, Philadelphia, 1988. [Google Scholar]
  • 2. Scherrmann J. M. in Comprehensive Medicinal Chemistry II (Eds.: J. B. Taylor, D. J. Triggle), Elsevier, Oxford, 2006, pp. 51–85. [Google Scholar]
  • 3. Ubarretxena-Belandia I., Engelman D. M., Curr. Opin. Struct. Biol. 2001, 11, 370–376. [DOI] [PubMed] [Google Scholar]
  • 4. Rice A. J., Park A., Pinkett H. W., Crit. Rev. Biochem. Mol. Biol. 2014, 49, 426–437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Borges-Walmsley M. I., McKeegan K. S., Walmsley A. R., Biochem. J. 2003, 376, 313–338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Borges-Walmsley M. I., Walmsley A. R., Trends Microbiol. 2001, 9, 71–79. [DOI] [PubMed] [Google Scholar]
  • 7. Hilger D., Masureel M., Kobilka B. K., Nat. Struct. Mol. Biol. 2018, 25, 4–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Wallin E., Von Heijne G., Protein Sci. 1998, 7, 1029–1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Chou K. C., Elrod D. W., Proteins Struct. Funct. Genet. 1999, 34, 137–153. [PubMed] [Google Scholar]
  • 10. Gong J., Chen Y., Pu F., Sun P., He F., Zhang L., Li Y., Ma Z., Wang H., Curr. Drug Targets 2018, 20, 551–564. [DOI] [PubMed] [Google Scholar]
  • 11. Overington J. P., Al-Lazikani B., Hopkins A. L., Nat. Rev. Drug Discovery 2006, 5, 993–996. [DOI] [PubMed] [Google Scholar]
  • 12. Zhou H. X., Cross T. A., Annu. Rev. Biophys. 2013, 42, 361–392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Seddon A. M., Curnow P., Booth P. J., Biochim. Biophys. Acta Biomembr. 2004, 1666, 105–117. [DOI] [PubMed] [Google Scholar]
  • 14. Dowhan W., Bogdanov M., Biochem. Soc. Trans. 2011, 39, 767–774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Hunte C., Richers S., Curr. Opin. Struct. Biol. 2008, 18, 406–411. [DOI] [PubMed] [Google Scholar]
  • 16. Palsdottir H., Hunte C., Biochim. Biophys. Acta Biomembr. 2004, 1666, 2–18. [DOI] [PubMed] [Google Scholar]
  • 17. Martens C., Shekhar M., Borysik A. J., Lau A. M., Reading E., Tajkhorshid E., Booth P. J., Politis A., Nat. Commun. 2018, 9, 4151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Bowie J. U., Curr. Opin. Struct. Biol. 2001, 11, 397–402. [DOI] [PubMed] [Google Scholar]
  • 19. Duquesne K., Prima V., Sturgis J. N., Heterologous Expression of Membrane Proteins, Springer New York, New York, 2016. [Google Scholar]
  • 20. Privé G. G., Methods 2007, 41, 388–397. [DOI] [PubMed] [Google Scholar]
  • 21. Shao Z., Yin J., Chapman K., Grzemska M., Clark L., Wang J., Rosenbaum D. M., Nature 2016, 540, 602–606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Payandeh J., Scheuer T., Zheng N., Catterall W. A., Nature 2011, 475, 353–359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Schmidt H. R., Zheng S., Gurpinar E., Koehl A., Manglik A., Kruse A. C., Nature 2016, 532, 527–530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Sonoda Y., Newstead S., Hu N. J., Alguel Y., Nji E., Beis K., Yashiro S., Lee C., Leung J., Cameron A. D., Byrne B., Iwata S., Drew D., Structure 2011, 19, 17–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Chipot C., Dehez F., Schnell J. R., Zitzmann N., Pebay-Peyroula E., Catoire L. J., Miroux B., Kunji E. R. S., Veglia G., Cross T. A., Schanda P., Chem. Rev. 2018, 118, 3559–3607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Stetsenko A., Guskov A., Crystals 2017, 7, 197. [Google Scholar]
  • 27. Rédei G. P., Encyclopedia of Genetics, Genomics, Proteomics, and Informatics, Vol. 62, Springer, Heidelberg, 2008, pp. 1142-1142. [Google Scholar]
  • 28. Reddy V. S., Shlykov M. A., Castillo R., Sun E. I., Saier M. H., FEBS J. 2012, 279, 2022–2035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Yan N., Annu. Rev. Biophys. 2015, 44, 257–283. [DOI] [PubMed] [Google Scholar]
  • 30. Jardetzky O., Nature 1966, 211, 969–970. [DOI] [PubMed] [Google Scholar]
  • 31. Abramson J., Smirnova I., Kasho V., Verner G., Kaback H. R., Iwata S., Science 2003, 301, 610–615. [DOI] [PubMed] [Google Scholar]
  • 32. Forrest L. R., Krämer R., Ziegler C., Biochim. Biophys. Acta Bioenerg. 2011, 1807, 167–188. [DOI] [PubMed] [Google Scholar]
  • 33. Quistgaard E. M., Löw C., Guettou F., Nordlund P., Nat. Rev. Mol. Cell Biol. 2016, 17, 123–132. [DOI] [PubMed] [Google Scholar]
  • 34. Marger M. D., Saier M. H., Trends Biochem. Sci. 1993, 18, 13–20. [DOI] [PubMed] [Google Scholar]
  • 35. Rubio-Aliaga I., Daniel H., Xenobiotica 2008, 38, 1022–1042. [DOI] [PubMed] [Google Scholar]
  • 36. Brandsch M., Expert Opin. Drug Metab. Toxicol. 2009, 5, 887–905. [DOI] [PubMed] [Google Scholar]
  • 37. Giacomini K. M., Huang S. M., Tweedie D. J., Benet L. Z., Brouwer K. L. R., Chu X., Dahlin A., Evers R., Fischer V., Hillgren K. M., Hoffmaster K. A., Ishikawa T., Keppler D., Kim R. B., Lee C. A., Niemi M., Polli J. W., Sugiyama Y., Swaan P. W., Ware J. A., Wright S. H., Wah Yee S., Zamek-Gliszczynski M. J., Zhang L., Nat. Rev. Drug Discovery 2010, 9, 215–236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Dantzig A. H., Bergin L., Biochim. Biophys. Acta Biomembr. 1990, 1027, 211–217. [DOI] [PubMed] [Google Scholar]
  • 39. Biegel A., Gebauer S., Hartrodt B., Brandsch M., Neubert K., Thondorf I., J. Med. Chem. 2005, 48, 4410–4419. [DOI] [PubMed] [Google Scholar]
  • 40. Boggavarapu R., Jeckelmann J. M., Harder D., Ucurum Z., Fotiadis D., BMC Biol. 2015, 13, 58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Doki S., Kato H. E., Solcan N., Iwaki M., Koyama M., Hattori M., Iwase N., Tsukazaki T., Sugita Y., Kandori H., Newstead S., Ishitani R., Nureki O., Proc. Natl. Acad. Sci. USA 2013, 110, 11343–11348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Minhas G. S., Newstead S., Proc. Natl. Acad. Sci. USA 2019, 116, 804–809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Newstead S., Drew D., Cameron A. D., Postis V. L. G., Xia X., Fowler P. W., Ingram J. C., Carpenter E. P., Sansom M. S. P., McPherson M. J., Baldwin S. A., Iwata S., EMBO J. 2011, 30, 417–426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Parker J. L., Li C., Brinth A., Wang Z., Vogeley L., Solcan N., Ledderboge-Vucinic G., Swanson J. M. J., Caffrey M., Voth G. A., Newstead S., Proc. Natl. Acad. Sci. USA 2017, 114, 13182–13187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Parker J. L., Newstead S., Nature 2014, 507, 68–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Quistgaard E. M., Molledo M. M., Löw C., PLoS One 2017, 12, e0173126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Solcan N., Kwok J., Fowler P. W., Cameron A. D., Drew D., Iwata S., Newstead S., EMBO J. 2012, 31, 3411–3421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Ural-Blimke Y., Flayhan A., Strauss J., Rantos V., Bartels K., Nielsen R., Pardon E., Steyaert J., Kosinski J., Quistgaard E. M., Löw C., J. Am. Chem. Soc. 2019, 141, 2404–2412. [DOI] [PubMed] [Google Scholar]
  • 49. Zhao Y., Mao G., Liu M., Zhang L., Wang X., Zhang X. C., Structure 2014, 22, 1152–1160. [DOI] [PubMed] [Google Scholar]
  • 50. Fowler P. W., Orwick-Rydmark M., Radestock S., Solcan N., Dijkman P. M., Lyons J. A., Kwok J., Caffrey M., Watts A., Forrest L. R., Newstead S., Structure 2015, 23, 290–301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Guettou F., Quistgaard E. M., Raba M., Moberg P., Löw C., Nordlund P., Nat. Struct. Mol. Biol. 2014, 21, 728–731. [DOI] [PubMed] [Google Scholar]
  • 52. Guettou F., Quistgaard E. M., Trésaugues L., Moberg P., Jegerschöld C., Zhu L., Jong A. J. O., Nordlund P., Löw C., EMBO Rep. 2013, 14, 804–810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Huang C. Y., Olieric V., Ma P., Howe N., Vogeley L., Liu X., Warshamanage R., Weinert T., Panepucci E., Kobilka B., Diederichs K., Wang M., Caffrey M., Acta Crystallogr. Sect. D 2016, 72, 93–112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Lyons J. A., Parker J. L., Solcan N., Brinth A., Li D., Shah S. T., Caffrey M., Newstead S., EMBO Rep. 2014, 15, 886–893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Martinez Molledo M., Quistgaard E. M., Flayhan A., Pieprzyk J., Löw C., Structure 2018, 26, 467–476.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Martinez Molledo M., Quistgaard E. M., Löw C., FEBS Lett. 2018, 592, 3239–3247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Minhas G. S., Bawdon D., Herman R., Rudden M., Stone A. P., James A. G., Thomas G. H., Newstead S., eLife 2018, 7, e34995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Harder D., Stolz J., Casagrande F., Obrdlik P., Weitz D., Fotiadis D., Daniel H., FEBS J. 2008, 275, 3290–3298. [DOI] [PubMed] [Google Scholar]
  • 59. Bippes C. A., Ge L., Meury M., Harder D., Ucurum Z., Daniel H., Fotiadis D., Müller D. J., Proc. Natl. Acad. Sci. USA 2013, 110, 3978–3986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Daniel H., Spanier B., Kottra G., Weitz D., Physiology 2006, 21, 93–102. [DOI] [PubMed] [Google Scholar]
  • 61. Brandsch M., Curr. Opin. Pharmacol. 2013, 13, 881–887. [DOI] [PubMed] [Google Scholar]
  • 62. Brandsch M., Knütter I., Leibach F. H., Eur. J. Pharm. Sci. 2004, 21, 53–60. [DOI] [PubMed] [Google Scholar]
  • 63. Ocheltree S. M., Shen H., Hu Y., Keep R. F., Smith D. E., J. Pharmacol. Exp. Ther. 2005, 315, 240–247. [DOI] [PubMed] [Google Scholar]
  • 64. Weitz D., Harder D., Casagrande F., Fotiadis D., Obrdlik P., Kelety B., Daniel H., J. Biol. Chem. 2007, 282, 2832–2839. [DOI] [PubMed] [Google Scholar]
  • 65. Prabhala B. K., Aduri N. G., Iqbal M., Rahman M., Gajhede M., Hansen P. R., Mirza O., Res. Microbiol. 2017, 168, 443–449. [DOI] [PubMed] [Google Scholar]
  • 66. Beale J. H., Parker J. L., Samsudin F., Barrett A. L., Senan A., Bird L. E., Scott D., Owens R. J., Sansom M. S. P., Tucker S. J., Meredith D., Fowler P. W., Newstead S., Structure 2015, 23, 1889–1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Ashok Y., Nanekar R., Jaakola V. P., Protein Eng. Des. Sel. 2015, 28, 539–542. [DOI] [PubMed] [Google Scholar]
  • 68. Rosenbaum D. M., Zhang C., Lyons J. A., Holl R., Aragao D., Arlow D. H., Rasmussen S. G. F., Choi H. J., Devree B. T., Sunahara R. K., Chae P. S., Gellman S. H., Dror R. O., Shaw D. E., Weis W. I., Caffrey M., Gmeiner P., Kobilka B. K., Nature 2011, 469, 236–242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. White J. F., Noinaj N., Shibata Y., Love J., Kloss B., Xu F., Gvozdenovic-Jeremic J., Shah P., Shiloach J., Tate C. G., Grisshammer R., Nature 2012, 490, 508–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Cho K. H., Bae H. E., Das M., Gellman S. H., Chae P. S., Chem. Asian J. 2014, 9, 632–638. [DOI] [PubMed] [Google Scholar]
  • 71. Granier S., Manglik A., Kruse A. C., Kobilka T. S., Thian F. S., Weis W. I., Kobilka B. K., Nature 2012, 485, 400–404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Haga K., Kruse A. C., Asada H., Yurugi-Kobayashi T., Shiroishi M., Zhang C., Weis W. I., Okada T., Kobilka B. K., Haga T., Kobayashi T., Nature 2012, 482, 547–551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Kruse A. C., Hu J., Pan A. C., Arlow D. H., Rosenbaum D. M., Rosemond E., Green H. F., Liu T., Chae P. S., Dror R. O., Shaw D. E., Weis W. I., Wess J., Kobilka B. K., Nature 2012, 482, 552–556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Manglik A., Kruse A. C., Kobilka T. S., Thian F. S., Mathiesen J. M., Sunahara R. K., Pardo L., Weis W. I., Kobilka B. K., Granier S., Nature 2012, 485, 321–326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Rasmussen S. G. F., Devree B. T., Zou Y., Kruse A. C., Chung K. Y., Kobilka T. S., Thian F. S., Chae P. S., Pardon E., Calinski D., Mathiesen J. M., Shah S. T. A., Lyons J. A., Caffrey M., Gellman S. H., Steyaert J., Skiniotis G., Weis W. I., Sunahara R. K., Kobilka B. K., Nature 2011, 477, 549–557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Ring A. M., Manglik A., Kruse A. C., Enos M. D., Weis W. I., Garcia K. C., Kobilka B. K., Nature 2013, 502, 575–579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Rollauer S. E., Tarry M. J., Graham J. E., Jääskeläinen M., Jäger F., Johnson S., Krehenbrink M., Liu S. M., Lukey M. J., Marcoux J., McDowell M. A., Rodriguez F., Roversi P., Stansfeld P. J., Robinson C. V., Sansom M. S. P., Palmer T., Högbom M., Berks B. C., Lea S. M., Nature 2012, 492, 210–214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Gopich I. V., Szabo A., Proc. Natl. Acad. Sci. USA 2012, 109, 7747–7752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Kalinin S., Valeri A., Antonik M., Felekyan S., Seidel C. A. M., J. Phys. Chem. B 2010, 114, 7983–7995. [DOI] [PubMed] [Google Scholar]
  • 80. Soranno A., Buchli B., Nettels D., Cheng R. R., Müller-Späth S., Pfeil S. H., Hoffmann A., Lipman E. A., Makarov D. E., Schuler B., Proc. Natl. Acad. Sci. USA 2012, 109, 17800–17806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Haas E., Wilchek M., Katchalski-Katzir E., Steinberg I. Z., Proc. Natl. Acad. Sci. USA 1975, 72, 1807–1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Wuttke R., Hofmann H., Nettels D., Borgia M. B., Mittal J., Best R. B., Schuler B., Proc. Natl. Acad. Sci. USA 2014, 111, 5213–5218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Nettels D., Müller-Späth S., Küster F., Hofmann H., Haenni D., Rüegger S., Reymond L., Hoffmann A., Kubelka J., Heinz B., Gast K., Best R. B., Schuler B., Proc. Natl. Acad. Sci. USA 2009, 106, 20740–20745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Hoffmann A., Nettels D., Clark J., Borgia A., Radford S. E., Clarke J., Schuler B., Phys. Chem. Chem. Phys. 2011, 13, 1857–1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Grossman I., Aviram H. Y., Armony G., Horovitz A., Hofmann H., Haran G., Fass D., Nat. Commun. 2015, 6, 8624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Jiang X., Ermolova N., Lim J., Choi S. W., Kaback H. R., Proc. Natl. Acad. Sci. USA 2020, 117, 977–981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Flayhan A., Mertens H. D. T., Ural-Blimke Y., Martinez Molledo M., Svergun D. I., Löw C., Structure 2018, 26, 345–355.e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Frauenfeld J., Löving R., Armache J. P., Sonnen A. F. P., Guettou F., Moberg P., Zhu L., Jegerschöld C., Flayhan A., Briggs J. A. G., Garoff H., Löw C., Cheng Y., Nordlund P., Nat. Methods 2016, 13, 345–351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Oursel D., Loutelier-Bourhis C., Orange N., Chevalier S., Norris V., Lange C. M., Rapid Commun. Mass Spectrom. 2007, 21, 1721–1728. [DOI] [PubMed] [Google Scholar]
  • 90. Van Meer G., Voelker D. R., Feigenson G. W., Nat. Rev. Mol. Cell Biol. 2008, 9, 112–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Gore S., Sanz García E., Hendrickx P. M. S., Gutmanas A., Westbrook J. D., Yang H., Feng Z., Baskaran K., Berrisford J. M., Hudson B. P., Ikegawa Y., Kobayashi N., Lawson C. L., Mading S., Mak L., Mukhopadhyay A., Oldfield T. J., Patwardhan A., Peisach E., Sahni G., Sekharan M. R., Sen S., Shao C., Smart O. S., Ulrich E. L., Yamashita R., Quesada M., Young J. Y., Nakamura H., Markley J. L., Berman H. M., Burley S. K., Velankar S., Kleywegt G. J., Structure 2017, 25, 1916–1927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Ernst H. A., Pham A., Hald H., Kastrup J. S., Rahman M., Mirza O., Biochem. Biophys. Res. Commun. 2009, 389, 112–116. [DOI] [PubMed] [Google Scholar]
  • 93. Parker J. L., Mindell J. A., Newstead S., eLife 2014, 3, e04273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Berardi M. J., Shih W. M., Harrison S. C., Chou J. J., Nature 2011, 476, 109–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Zhao L., Wang S., Zhu Q., Wu B., Liu Z., OuYang B., Chou J. J., Structure 2017, 25, 1371–1379.e3. [DOI] [PubMed] [Google Scholar]
  • 96. Matar-Merheb R., Rhimi M., Leydier A., Huché F., Galián C., Desuzinges-Mandon E., Ficheux D., Flot D., Aghajari N., Kahn R., Di Pietro A., Jault J. M., Coleman A. W., Falson P., PLoS One 2011, 6, e18036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Casiraghi M., Damian M., Lescop E., Point E., Moncoq K., Morellet N., Levy D., Marie J., Guittet E., Banères J. L., Catoire L. J., J. Am. Chem. Soc. 2016, 138, 11170–11175. [DOI] [PubMed] [Google Scholar]
  • 98. Thomas J., Tate C. G., J. Mol. Biol. 2014, 426, 4139–4154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Kalienkova V., Mosina V. C., Bryner L., Oostergetel G. T., Dutzler R., Paulino C., eLife 2019, 8, e44364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Truong-Quang B. A., Lenne P. F., Front. Plant Sci. 2014, 5, 18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Aviram H. Y., Pirchi M., Mazal H., Barak Y., Riven I., Haran G., Proc. Natl. Acad. Sci. USA 2018, 115, 3243–3248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Grossman-Haham I., Rosenblum G., Namani T., Hofmann H., Proc. Natl. Acad. Sci. USA 2018, 115, 513–518. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supplementary


Articles from Angewandte Chemie (International Ed. in English) are provided here courtesy of Wiley

RESOURCES